Murine gammaherpesvirus 68 infection of IFNγ unresponsive mice: A small animal model for gammaherpesvirus-associated B-cell lymphoproliferative disease

Cancer Research

Volumn 69, Issue 13, 2009, Pages 5481-5489

  Lee, Katherine S ^a   Groshong, Steve D ^b   Cool, Carlyne D ^a,b   Kleinschmidt DeMasters, Bette K ^a   Van Dyk, Linda F ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b DEPARTMENT OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; CANCER REGRESSION; CONTROLLED STUDY; DISEASE COURSE; DISEASE MODEL; EMBRYO; GAMMAHERPESVIRUS 68; HERPES VIRUS; HERPES VIRUS INFECTION; KNOCKOUT MOUSE; LUNG B CELL LYMPHOMA; LYMPHOID HYPERPLASIA; LYMPHOMATOID GRANULOMATOSIS; LYMPHOPROLIFERATIVE DISEASE; MOUSE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; VIRUS REACTIVATION; VIRUS VIRULENCE; WILD TYPE;

ANIMALS; B-LYMPHOCYTES; DISEASE MODELS, ANIMAL; FIBROBLASTS; GAMMAHERPESVIRINAE; HERPESVIRIDAE INFECTIONS; INFLAMMATION; INTERFERON-GAMMA; LUNG; LYMPHOPROLIFERATIVE DISORDERS; MICE; NEOPLASMS; PULMONARY CIRCULATION; VIRUS REPLICATION;

EID: 67650446577     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-09-0291     Document Type: Article

References (50)

1. Virgin HW, Latreille P, Wamsley P, et al. Complete sequence and genomic analysis of murine gammaherpesvirus 68. J Virol 1997;71:5894-904.
2. Flano E, Husain SM, Sample JT, Woodland DL, Blackman MA. Latent murine {gamma}-herpesvirus infection is established in activated B cells, dendritic cells, and macrophages. J Immunol 2000;165:1074-81.
3. Stewart JP, Usherwood EJ, Ross A, Dyson H, Nash T. Lung epithelial cells are a major site of murine gammaherpesvirus persistence. J Exp Med 1998;187:1941-51.
4. Simas JP, Efstathiou S. Murine gammaherpesvirus 68: a model for the study of gammaherpesvirus pathogenesis. Trends Microbiol 1998;6:276-82.
5. Doherty PC, Tripp RA, Hamilton-Easton AM, et al. Tuning into immunological dissonance: an experimental model for infectious mononucleosis. Curr Opin Immunol 1997;9:477-83.
6. Weck KE, Dal Canto AJ, Gould JD, et al. Murine gamma-herpesvirus 68 causes severe large-vessel arteritis in mice lacking interferon-γ responsiveness: a new model for virus-induced vascular disease. Nat Med 1997;3:1346-53.
7. Mora AL, Woods CR, Garcia A. Lung infection with gamma-herpesvirus induces progressive pulmonary fibrosis in Th2-biased mice. Am J Physiol Lung Cell Mol Physiol 2005;289:L711-21.
8. Kaplan DH, Shankaran V, Dighe AS, et al. Demonstration of an interferon γ-dependent tumor surveillance system in immunocompetent mice. Proc Natl Acad Sci U S A 1998; 95:7556-61.
9. Sunil-Chandra NP, Arno J, Fazakerley J, Nash AA. Lymphoproliferative disease inmice infected with murine gammaherpesvirus 68. Am J Pathol 1994;145:818-26.
10. Tarakanova VL, Suarez F, Tibbetts SA, et al. Murine gammaherpesvirus 68 infection is associated with lymphoproliferative disease and lymphoma in BALB {beta}2 microglobulin-deficient mice. J Virol 2005;79:14668-79.
11. Dutia BM, Allen DJ, Dyson H, Nash AA. Type I interferons and IRF-1 play a critical role in the control of a gammaherpesvirus infection. Virology 1999;261:173-9.
12. Sarawar SR, Cardin RD, Brooks JW, et al. γ Interferon is not essential for recovery from acute infection with murine gammaherpesvirus 68. J Virol 1997;71:3916-21.
13. Steed AL, Barton ES, Tibbetts SA, et al. γ Interferon blocks gammaherpesvirus reactivation from latency. J Virol 2006;80:192-200.
14. Tibbetts SA, vanDyk LF, Speck SH, Virgin HW IV. Immune control of the number and reactivation phenotype of cells latently infected with a gammaherpesvirus. J Virol 2002;76:7125-32.
15. Ebrahimi B, Dutia BM, Brownstein DG, Nash AA. Murine gammaherpesvirus-68 infection causes multiorgan fibrosis and alters leukocyte trafficking in interferon-{{gamma}} receptor knockout mice. Am J Pathol 2001;158:2117-25.
16. Dal Canto AJ, Virgin HW IV, Speck SH. Ongoing viral replication is required for gammaherpesvirus 68-induced vascular damage. J Virol 2000;74:11304-10.
17. Mora AL, Torres-Gonzalez E, Rojas M, et al. Control of virus reactivation arrests pulmonary herpesvirus-induced fibrosis in IFN-γ receptor-deficient mice. Am J Respir Crit Care Med 2007;175:1139-50.
18. van Dyk LF, Virgin HW IV, Speck SH. The murine gammaherpesvirus 68 v-cyclin is a critical regulator of reactivation from latency. J Virol 2000;74:7451-61.
19. Gangappa S, van Dyk LF, Jewett TJ, Speck SH, Virgin HW IV. Identification of the in vivo role of a viral bcl-2. J Exp Med 2002;195:931-40.
20. van Dyk LF, Virgin HW IV, Speck SH. Maintenance of gammaherpesvirus latency requires viral cyclin in the absence of B lymphocytes. J Virol 2003;77:5118-26.
21. Liebow AA, Carrington CR, Friedman PJ. Lymphomatoid granulomatosis. Hum Pathol 1972;3:457-558.
22. Haque AK, Myers JL, Hudnall SD, et al. Pulmonary lymphomatoid granulomatosis in acquired immunodeficiency syndrome: lesions with Epstein-Barr virus infection. Mod Pathol 1998;11:347-56.
23. Hochberg EP, Gilman MD, Hasserjian RP. Case records of the Massachusetts General Hospital. Case 17-2006 - a 34-year-old man with cavitary lung lesions. N Engl J Med 2006;354:2485-93.
24. Nicholson AG. Pulmonary lymphoproliferative disorders. Current Diagnostic Pathology 2000;6:130-9.
25. Weiss LM, Jaffe ES, Liu XF, et al. Detection and localization of Epstein-Barr viral genomes in angioimmunoblastic lymphadenopathy and angioimmunoblastic lymphadenopathy-like lymphoma. Blood 1992;79:1789-95.
26. Beaty MW, Toro J, Sorbara L, et al. Cutaneous lymphomatoid granulomatosis: correlation of clinical and biologic features. Am J Surg Pathol 2001;25:1111-20.
27. Katzenstein AL, Carrington CB, Liebow AA. Lymphomatoid granulomatosis: a clinicopathologic study of 152 cases. Cancer 1979;43:360-73.
28. Wilson WH, Kingma DW, Raffeld M, Wittes RE, Jaffe ES. Association of lymphomatoid granulomatosis with Epstein-Barr viral infection of B lymphocytes and response to interferon-α 2b. Blood 1996;87:4531-7.
29. Carbone A, Cesarman E, Spina M, Gloghini A, Schulz TF. HIV-associated lymphomas and gammaherpesviruses. Blood 2009;113:1213-24.
30. Rezk SA, Weiss LM. Epstein-Barr virus-associated lymphoproliferative disorders. Hum Pathol 2007;38:1293-304.
31. Cachat F, Meagher-Villemure K, Guignard JP. Lymphomatoid granulomatosis in a renal transplant patient. Pediatr Nephrol 2003;18:838-42.
32. Cohen ML, Dawkins RL, Henderson DW, Sterrett GF, Papadimitriou JM. Pulmonary lymphomatoid granulomatosis with immunodeficiency terminating as malignant lymphoma. Pathology 1979;11:537-50.
33. Fassas A, Jagannath S, Desikan KR, et al. Lymphomatoid granulomatosis following autologous stem cell transplantation. Bone Marrow Transplant 1999;23:79-81.
34. Aozasa K. Pyothorax-associated lymphoma. J Clin Exp Hematop 2006;46:5-10.
35. Hara S, Kami M, Miyakoshi S, et al. Central nervous system involvement in pyothorax-associated lymphoma: ring enhancement on CT scan. Ann Hematol 2001;80:174-7.
36. Loddenkemper C, Hoecht S, Anagnostopoulos I, et al. A62-year -old man with chronic pyothorax. Brain Pathol 2005;15:371-3.
37. Androulaki A, Drakos E, Hatzianastassiou D, et al. Pyothorax-associated lymphoma (PAL): a western case with marked angiocentricity and review of the literature. Histopathology 2004;44:69-76.
38. Iuchi K, Aozasa K, Yamamoto S, et al. Non-Hodgkin's lymphoma of the pleural cavity developing from long-standing pyothorax. Summary of clinical and pathological findings in thirty-seven cases. Jpn J Clin Oncol 1989;19:249-57.
39. Taniere P, Manai A, Charpentier R, et al. Pyothorax-associated lymphoma: relationship with Epstein-Barr virus, human herpes virus-8 and body cavity-based high grade lymphomas. Eur Respir J 1998;11:779-83.
40. Weck KE, Barkon ML, Yoo LI, Speck SH, Virgin HW IV. Mature B cells are required for acute splenic infection, but not for establishment of latency, by murine gammaherpesvirus 68. J Virol 1996;70:6775-80.
41. Huang S, Hendriks W, Althage A, et al. Immune response in mice that lack the interferon-γ receptor. Science 1993;259:1742-5.
42. Pfeffer S, Sewer A, Lagos-Quintana M, et al. Identification of microRNAs of the herpesvirus family. Nat Methods 2005;2:269-76.
43. Virgin HW IV, Presti RM, Li XY, Liu C, Speck SH. Three distinct regions of the murine gammaherpesvirus 68 genome are transcriptionally active in latently infected mice. J Virol 1999;73:2321-32.
44. Szekely L, Chen F, Teramoto N. Restricted expression of Epstein-Barr virus (EBV)-encoded, growth transformation-associated antigens in an EBV- and human herpesvirus type 8-carrying body cavity lymphoma line [published erratum appears in J Gen Virol 1998 Nov;79(Pt 11):2875]. J Gen Virol 1998;79:1445-52.
45. Zhong W, Wang H, Herndier B, Ganem D. Restricted expression of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genes in Kaposi sarcoma. Proc Natl Acad Sci U S A 1996;93:6641-6.
46. Usherwood EJ, Ross AJ, Allen DJ, Nash AA. Murine gammaherpesvirus-induced splenomegaly: a critical role for CD4 T cells. J Gen Virol 1996;77:627-30.
47. Wu TT, Usherwood EJ, Stewart JP, Nash AA, Sun R. Rta of murine gammaherpesvirus 68 reactivates the complete lytic cycle from latency. J Virol 2000;74:3659-67.
48. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70.
49. Dierksheide JE, Baiocchi RA, Ferketich AK, et al. IFN-{gamma} gene polymorphisms associate with development of EBV+ lymphoproliferative disease in hu PBL-SCID mice. Blood 2005;105:1558-65.
50. Teruya-Feldstein J, Jaffe ES, Burd PR, et al. The role of Mig, the monokine induced by interferon-γ, and IP-10, the interferon-γ- inducible protein-10, in tissue necrosis and vascular damage associated with Epstein-Barr virus-positive lymphoproliferative disease. Blood 1997;90:4099-105.